Availability of Gentamicin Ampoules

To address the anticipated supply interruption of Pfizer Gentamicin ampoules from Nov 2024 to March 2025, HPS will move Gentamicin Injection 80mg/2mL to Gentamicin Noridem (supplied by Interpharma) effective from 17th June 2024.

Gentamicin Noridem
Gentamicin (as sulfate) 80mg/2mL
ARTG 391250

Gentamicin Noridem is an Australian registered product that also contains gentamicin (as sulfate) 80mg/2mL. This is a suitable alternative in most situations. However, this product contains sodium metabisulfite as a preservative. In susceptible people, this sulfite can cause allergic-type reactions, which may be severe.

In comparison, the Pfizer Gentamicin product does not contain any antimicrobial preservative. This should be taken into consideration, particularly for healthcare professionals who may have used Pfizer Gentamicin injection ampoules via an alternative route of administration. In these cases, clinicians may need to consider other therapies. If a sulfite-free gentamicin product is required, the possibility of supply via the Special Access Scheme (SAS) could be explored on a case-by-case basis. The lead time for accessing SAS stock is longer and ongoing availability is not certain.

Retain this notice in a prominent position, including in other related business units. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your  pharmacist at HPS Pharmacies.

Download PDF